Andrew J. Stewart - 24 Apr 2023 Form 3 Insider Report for Bausch & Lomb Corp (BLCO)

Role: Officer
Signature: /s/ Debra E. Levin, attorney-in-fact
Issuer symbol: BLCO
Transactions as of: 24 Apr 2023
Net transactions value: $0
Form type: 3
Filing time: 26 Apr 2023, 17:14:21 UTC
Next filing: 01 Mar 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

The Reporting Person's title as an officer of the Issuer is President, Ophthalmic Pharmaceuticals. Exhibit 24 - Power of Attorney